Composition: Loteprednol Etabonate 0.5% w/v
Formulation: Eye Drops
Category: Corticosteroid
Packaging: 5ML






Therapy/Class: Corticosteroid
Mechanism of Action:
Loteprednol Etabonate: A retrometabolic, ester-based ‘soft’ corticosteroid structurally designed to provide potent localized immunosuppressive and anti-inflammatory effects, followed by predictable, rapid de-esterification into inactive carboxylic acid metabolites. This mechanism dramatically mitigates the propensity for steroid-induced intraocular pressure (IOP) elevation.
Treatment of steroid-responsive ocular inflammatory conditions
Management of post-surgical ocular inflammation and edema
Note: This is an indicative Indication, please follow the doctors advise. Do not self medicate.
Instill 1 drop into the inferior conjunctival cul-de-sac of the affected eye(s) as prescribed by the physician. Dosing frequency should be adjusted according to clinical response and severity.
Note: This is an indicative dosage, please follow the doctors advise. Do not self medicate.
1. Sheppard JD, et al. Loteprednol etabonate ophthalmic suspension 0.5% in the treatment of post-operative inflammation. Clin Ophthalmol. 2014;8:2101-2110.
2. Comstock TL, et al. Safety and efficacy of loteprednol etabonate in ocular surgery. J Ocul Pharmacol Ther. 2012;28(4):359-366.
Warning: This information is only for the use of registered medical practitioners only.
Error: Contact form not found.
